Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Edesa Biotech Inc.

    NASDAQ: EDSA · Real-Time Price · USD
    2.03
    -0.02 (-0.98%)
    At close: Jun 30, 2025, 3:59 PM
    1.97
    -2.96%
    After-hours: Jun 30, 2025, 07:47 PM EDT

    Edesa Biotech Statistics

    Share Statistics

    Edesa Biotech has 7.02M shares outstanding. The number of shares has increased by 117.43% in one year.

    Shares Outstanding

    n/a
    		 7.02M

    Shares Change (YoY)

    n/a
    		 117.43%

    Shares Change (QoQ)

    n/a
    		 101.65%

    Owned by Institutions (%)

    n/a
    		 6.2%

    Shares Floating

    n/a
    		 5.36M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,681

    FTD / Avg. Volume

    n/a
    		 8.69%

    Short Selling Information

    The latest short interest is 28.92K, so 0.41% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 28.92K

    Short % of Shares Out

    n/a
    		 0.41%

    Short % of Float

    n/a
    		 0.48%

    Short Ratio (days to cover)

    n/a
    		 1.55

    Valuation Ratios

    The PE ratio is -2.31 and the forward PE ratio is -0.82. Edesa Biotech's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -2.31

    Forward PE

    n/a
    		 -0.82

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.5

    PB Ratio

    n/a
    		 7.18

    P/FCF Ratio

    n/a
    		 -2.91

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Edesa Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 0.91

    Quick Ratio

    n/a
    		 0.91

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-385,627.81

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 800

    Effective Tax Rate

    n/a
    		 -0.01%

    Stock Price Statistics

    The stock price has increased by -52.34% in the last 52 weeks. The beta is 0.38, so Edesa Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.38

    52-Week Price Change

    n/a
    		 -52.34%

    50-Day Moving Average

    n/a
    		 2.1

    200-Day Moving Average

    n/a
    		 2.51

    Relative Strength Index (RSI)

    n/a
    		 52.89

    Average Volume (20 Days)

    n/a
    		 19,340

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -7.01M

    Net Income

    n/a
    		 -6.17M

    EBITDA

    n/a
    		 -5.98M

    EBIT

    n/a
    		 -6.32M

    Earnings Per Share (EPS)

    n/a
    		 -1.93
    Full Income Statement

    Balance Sheet

    The company has 1.04M in cash and 19.87K in debt, giving a net cash position of 1.02M.

    Cash & Cash Equivalents

    n/a
    		 1.04M

    Total Debt

    n/a
    		 19.87K

    Net Cash

    n/a
    		 1.02M

    Retained Earnings

    n/a
    		 -58.59M

    Total Assets

    n/a
    		 16.45M

    Working Capital

    n/a
    		 13.47M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.89M and capital expenditures 0, giving a free cash flow of -4.89M.

    Operating Cash Flow

    n/a
    		 -4.89M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.89M

    FCF Per Share

    n/a
    		 -1.53
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    EDSA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EDSA is $5, which is 145.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 145.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 11, 2023. It was a backward split with a ratio of 1:7.

    Last Split Date

    n/a
    		 Oct 11, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:7

    Scores

    Altman Z-Score

    n/a
    		 3.71

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist